سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Ghezel, Ava, Arfaee, Chista. (1403). COVID-19 vaccination and long COVID-19. , 12(1), 32-33. doi: 10.22038/rcm.2025.83612.1513
Ava Ghezel; Chista Sarira Arfaee. "COVID-19 vaccination and long COVID-19". , 12, 1, 1403, 32-33. doi: 10.22038/rcm.2025.83612.1513
Ghezel, Ava, Arfaee, Chista. (1403). 'COVID-19 vaccination and long COVID-19', , 12(1), pp. 32-33. doi: 10.22038/rcm.2025.83612.1513
Ghezel, Ava, Arfaee, Chista. COVID-19 vaccination and long COVID-19. , 1403; 12(1): 32-33. doi: 10.22038/rcm.2025.83612.1513

COVID-19 vaccination and long COVID-19

Reviews in Clinical Medicine
مقاله 5، دوره 12، شماره 1، خرداد 2025، صفحه 32-33    اصل مقاله (697.07 K)
نوع مقاله: Original article
شناسه دیجیتال (DOI): 10.22038/rcm.2025.83612.1513
نویسندگان
Ava Ghezel1؛ Chista Sarira Arfaee* 2
1Department of Internal Medicine, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran.
2Department of Radiology, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
چکیده
According to the literature, COVID-19 vaccines reduce long COVID-19 symptoms such as cognitive dysfunction, kidney diseases, myalgia, and sleeping disorders (5-7). Therefore, the results of the meta-analysis support the clinical safety and efficacy of SARS-CoV-2 vaccines against long COVID-19. However, the available studies have several limitations: 1) there were individuals that exhibited natural improvement of long COVID-19 symptoms which may have been underestimated as vaccination in clinical setting; 2) studies used wide range of COVID-19 vaccines including both inactivated vaccines and mRNA COVID-19 vaccines. Thus, findings should be interpreted with caution. Since booster vaccines show great promise in both prevention of infection and progression, further research on boosters and omicron-specific vaccination is needed to be performed. Consequently, the current comprehensive literature recommends SARS-CoV-2 vaccine to reduce the risk of long COVID-19 in cases of progression. There are no findings of a negative effect of COVID-19 vaccination on worsening symptoms of COVID-19. Therefore, SARS-CoV-2 vaccination should be improved as soon as possible, especially offering a full course of vaccination. More research is needed to discover the mechanism of action of the COVID-19 vaccines on long COVID-19 in the future.
کلیدواژه‌ها
Vaccine؛ SARS-CoV-2؛ COVID-19؛ Long COVID
مراجع
  1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21(3):133-46. doi:1038/s41579-022-00846-2 [PMid:36639608]
  2. Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nature Reviews Immunology. 2023;23(10):618-34.
    doi:1038/s41577-023-00904-7
  3. Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. Long COVID science, research and policy. Nature Medicine. 2024:1-17. doi: 1038/s41591-024-03173-6 [PMid:39122965]
  4. Greenhalgh T, Sivan M, Perlowski A, Nikolich JŽ. Long COVID: a clinical update. The Lancet. 2024;404(10453):707-24. doi:1016/S0140-6736(24)01136-X [PMid:39096925]
  5. Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2022;19(19):12422. doi:3390/ijerph191912422 [PMid:36231717]
  6. Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain, behavior, and immunity. 2023;111:211-29.doi:1016/j.bbi.2023.03.022 [PMid:36990297]
  7. Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783-90. doi:10.1016/j.vaccine.2023.02.008 [PMid:36774332]
آمار
تعداد مشاهده مقاله: 77
تعداد دریافت فایل اصل مقاله: 46